KAI Pharmaceuticals, Inc., a privately held drug discovery and
development company, today announced initiation of patient enrollment in
the second Phase 2 study of KAI-4169, a novel pharmaceutical ... read more
KAI Pharmaceuticals, Inc., a privately held drug discovery and
development company, today announced that results from the Company’s
Phase 2 study of KAI-4169 will be presented in a ... read more
KAI Pharmaceuticals, Inc., a privately held drug discovery and
development company, today announced the signing of an agreement with
Ono Pharmaceutical Co., Ltd. for the development and commercialization ... read more